Yokohama, Japan

Kohji Seio



Average Co-Inventor Count = 3.7

ph-index = 2

Forward Citations = 8(Granted Patents)


Location History:

  • Yokohama, JP (2009 - 2011)
  • Tokyo, JP (2022)

Company Filing History:


Years Active: 2009-2022

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Kohji Seio: Innovator in Nucleoside Research

Introduction

Kohji Seio is a prominent inventor based in Yokohama, Japan. He has made significant contributions to the field of nucleoside and nucleotide research, holding a total of 8 patents. His work focuses on developing compounds that enhance the stability and efficacy of nucleic acids.

Latest Patents

Kohji Seio's latest patents include innovations such as artificial nucleosides and artificial nucleotides. These compounds are capable of composing artificial oligonucleotides that exhibit superior nuclease resistance. His inventions are represented by complex chemical formulas that detail the structural components of these nucleosides. Additionally, he has developed 2'-hydroxyl group-modified ribonucleoside derivatives, which demonstrate excellent hybridization ability and resistance to nuclease degradation.

Career Highlights

Throughout his career, Kohji Seio has worked with esteemed institutions such as the Japan Science and Technology Agency and the Tokyo Institute of Technology. His research has significantly advanced the understanding of nucleic acid chemistry and its applications in biotechnology.

Collaborations

Kohji Seio has collaborated with notable colleagues, including Mitsuo Sekine and Akihiro Ohkubo. These partnerships have fostered innovative research and development in the field of nucleoside chemistry.

Conclusion

Kohji Seio's contributions to nucleoside and nucleotide research have established him as a key figure in the scientific community. His innovative patents continue to influence advancements in biotechnology and molecular biology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…